|
|
|
|
LEADER |
03104nam a22003855i 4500 |
001 |
978-3-540-72843-6 |
005 |
20191026142218.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 gw | s |||| 0|eng d |
020 |
|
|
|a 9783540728436
|
024 |
7 |
|
|a 10.1007/978-3-540-72843-6
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Protein-Protein Interactions as New Drug Targets
|c edited by Enno Klussmann, John Scott.
|
246 |
3 |
|
|a With contributions by numerous experts
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2008.
|
300 |
|
|
|a XV, 512 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|v 186
|
505 |
0 |
|
|a Organization of Scaffolds -- A-Kinase Anchoring Proteins as the Basis for cAMP Signaling -- Arrestins as Multi-Functional Signaling Adaptors -- Role of Ena/VASP Proteins in Homeostasis and Disease -- Scaffold/Matrix Attachment Regions (S/MARs): Relevance for Disease and Therapy -- Clathrin/AP-2-Dependent Endocytosis: A Novel Playground for the Pharmacological Toolbox? -- Scaffolding Proteins and Cellular Signalling -- PDE4 Associates with Different Scaffolding Proteins: Modulating Interactions as Treatment for Certain Diseases -- G-Protein-Coupled Receptor-Signaling Components in Membrane Raft and Caveolae Microdomains -- Protein Scaffolds, Lipid Domains and Substrate Recognition in Protein Kinase C Function: Implications for Rational Drug Design -- Compartmentalised MAPK Pathways -- Dynamic Protein Complexes Regulate NF-?B Signaling -- An Oncogenic Hub: ?-Catenin as a Molecular Target for Cancer Therapeutics -- A Toolkit for Real-Time Detection of cAMP: Insights into Compartmentalized Signaling -- Cell Type-Specific Anchoring -- Scaffolding Proteins in Cardiac Myocytes -- Molecular Architecture of Signal Complexes Regulating Immune Cell Function -- Scaffolding Proteins at the Postsynaptic Density: Shank as the Architectural Framework -- Interference with Protein-Protein Interaction Sites as a New Pharmacological Concept -- Domains Mediate Protein-Protein Interactions and Nucleate Protein Assemblies -- Proline-Rich Sequence Recognition Domains (PRD): Ligands, Function and Inhibition -- Chemical Inhibition Through Conformational Stabilization of Rho GTPase Effectors -- Pharmacological Interference with Protein-Protein Interactions Mediated by Coiled-Coil Motifs -- Direct AKAP-Mediated Protein-Protein Interactions as Potential Drug Targets.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Cell biology.
|
650 |
|
0 |
|a Medical biochemistry.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Cell Biology.
|
650 |
2 |
4 |
|a Medical Biochemistry.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
700 |
1 |
|
|a Klussmann, Enno.
|e editor.
|
700 |
1 |
|
|a Scott, John.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-540-72843-6
|